Neutrophil/lymphocyte ratio and other blood cell component counts are not associated with the development of postmolar gestational trophoblastic neoplasia

Detalhes bibliográficos
Autor(a) principal: Braga, Antonio
Data de Publicação: 2022
Outros Autores: Canelas, Ana Clara, Torres, Berenice, Maesta, Izildinha [UNESP], Giongo Pedrotti, Luana, Bessel, Marina, Vieira Dos Santos Esteves, Ana Paula, Amim Junior, Joffre, Rezende Filho, Jorge, Elias, Kevin M., Horowitz, Neil S., Berkowitz, Ross S.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1371/journal.pone.0277892
http://hdl.handle.net/11449/247975
Resumo: OBJECTIVE: To relate preevacuation platelet count and leukogram findings, especially neutrophil/lymphocyte ratios (NLR) and platelet/lymphocyte ratios with the occurrence of gestational trophoblastic neoplasia (GTN) after complete hydatidiform mole (CHM) among Brazilian women. METHODS: Retrospective cohort study of patients with CHM followed at Rio de Janeiro Federal University, from January/2015-December/2020. Before molar evacuation, all patients underwent a medical evaluation, complete blood count and hCG measurement, in addition to other routine preoperative tests. The primary outcome was the occurrence of postmolar GTN. RESULTS: From 827 cases of CHM treated initially at the Reference Center, 696 (84.15%) had spontaneous remission and 131 (15.85%) developed postmolar GTN. Using optimal cut-offs from receiver operating characteristic curves and multivariable logistic regression adjusted for the possible confounding variables of age and preevacuation hCG level (already known to be associated with the development of GTN) we found that ≥2 medical complications at presentation (aOR: 1.96, CI 95%: 1.29-2.98, p<0.001) and preevacuation hCG ≥100,000 IU/L (aOR: 2.16, CI 95%: 1.32-3.52, p<0.001) were significantly associated with postmolar GTN after CHM. However, no blood count profile findings were able to predict progression from CHM to GTN. CONCLUSION: Although blood count is a widely available test, being a low-cost test and mandatory before molar evacuation, and prognostic for outcome in other neoplasms, its findings were not able to predict the occurrence of GTN after CHM. In contrast, the occurrence of medical complications at presentation and higher preevacuation hCG levels were significantly associated with postmolar GTN and may be useful to guide individualized clinical decisions in post-molar follow-up and treatment of these patients.
id UNSP_c414ae7e0bf7b2d4d06b7c9f580556fa
oai_identifier_str oai:repositorio.unesp.br:11449/247975
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Neutrophil/lymphocyte ratio and other blood cell component counts are not associated with the development of postmolar gestational trophoblastic neoplasiaOBJECTIVE: To relate preevacuation platelet count and leukogram findings, especially neutrophil/lymphocyte ratios (NLR) and platelet/lymphocyte ratios with the occurrence of gestational trophoblastic neoplasia (GTN) after complete hydatidiform mole (CHM) among Brazilian women. METHODS: Retrospective cohort study of patients with CHM followed at Rio de Janeiro Federal University, from January/2015-December/2020. Before molar evacuation, all patients underwent a medical evaluation, complete blood count and hCG measurement, in addition to other routine preoperative tests. The primary outcome was the occurrence of postmolar GTN. RESULTS: From 827 cases of CHM treated initially at the Reference Center, 696 (84.15%) had spontaneous remission and 131 (15.85%) developed postmolar GTN. Using optimal cut-offs from receiver operating characteristic curves and multivariable logistic regression adjusted for the possible confounding variables of age and preevacuation hCG level (already known to be associated with the development of GTN) we found that ≥2 medical complications at presentation (aOR: 1.96, CI 95%: 1.29-2.98, p<0.001) and preevacuation hCG ≥100,000 IU/L (aOR: 2.16, CI 95%: 1.32-3.52, p<0.001) were significantly associated with postmolar GTN after CHM. However, no blood count profile findings were able to predict progression from CHM to GTN. CONCLUSION: Although blood count is a widely available test, being a low-cost test and mandatory before molar evacuation, and prognostic for outcome in other neoplasms, its findings were not able to predict the occurrence of GTN after CHM. In contrast, the occurrence of medical complications at presentation and higher preevacuation hCG levels were significantly associated with postmolar GTN and may be useful to guide individualized clinical decisions in post-molar follow-up and treatment of these patients.Department of Obstetrics and Gynecology Postgraduate Program in Perinatal Health Faculty of Medicine Maternity School of Rio de Janeiro Federal UniversityDepartment of Maternal Child Health Postgraduate Program in Medical Sciences Faculty of Medicine of Fluminense Federal UniversityNational Academy of Medicine Young Leadership Physicians ProgramPostgraduate Program in Applied Health Sciences Vassouras UniversityDepartment of Gynecology and Obstetrics Botucatu Trophoblastic Disease Center of the Clinical Hospital of Botucatu Medical School São Paulo State University - UNESPHospital Moinhos de VentoDepartment of Obstetrics Gynecology and Reproductive Biology New England Trophoblastic Disease Center Division of Gynecologic Oncology Brigham and Women's Hospital Harvard Medical SchoolDepartment of Gynecology and Obstetrics Botucatu Trophoblastic Disease Center of the Clinical Hospital of Botucatu Medical School São Paulo State University - UNESPMaternity School of Rio de Janeiro Federal UniversityFaculty of Medicine of Fluminense Federal UniversityYoung Leadership Physicians ProgramVassouras UniversityUniversidade Estadual Paulista (UNESP)Hospital Moinhos de VentoHarvard Medical SchoolBraga, AntonioCanelas, Ana ClaraTorres, BereniceMaesta, Izildinha [UNESP]Giongo Pedrotti, LuanaBessel, MarinaVieira Dos Santos Esteves, Ana PaulaAmim Junior, JoffreRezende Filho, JorgeElias, Kevin M.Horowitz, Neil S.Berkowitz, Ross S.2023-07-29T13:31:02Z2023-07-29T13:31:02Z2022-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlee0277892http://dx.doi.org/10.1371/journal.pone.0277892PloS one, v. 17, n. 12, p. e0277892-, 2022.1932-6203http://hdl.handle.net/11449/24797510.1371/journal.pone.02778922-s2.0-85143200909Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengPloS oneinfo:eu-repo/semantics/openAccess2023-07-29T13:31:02Zoai:repositorio.unesp.br:11449/247975Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462023-07-29T13:31:02Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Neutrophil/lymphocyte ratio and other blood cell component counts are not associated with the development of postmolar gestational trophoblastic neoplasia
title Neutrophil/lymphocyte ratio and other blood cell component counts are not associated with the development of postmolar gestational trophoblastic neoplasia
spellingShingle Neutrophil/lymphocyte ratio and other blood cell component counts are not associated with the development of postmolar gestational trophoblastic neoplasia
Braga, Antonio
title_short Neutrophil/lymphocyte ratio and other blood cell component counts are not associated with the development of postmolar gestational trophoblastic neoplasia
title_full Neutrophil/lymphocyte ratio and other blood cell component counts are not associated with the development of postmolar gestational trophoblastic neoplasia
title_fullStr Neutrophil/lymphocyte ratio and other blood cell component counts are not associated with the development of postmolar gestational trophoblastic neoplasia
title_full_unstemmed Neutrophil/lymphocyte ratio and other blood cell component counts are not associated with the development of postmolar gestational trophoblastic neoplasia
title_sort Neutrophil/lymphocyte ratio and other blood cell component counts are not associated with the development of postmolar gestational trophoblastic neoplasia
author Braga, Antonio
author_facet Braga, Antonio
Canelas, Ana Clara
Torres, Berenice
Maesta, Izildinha [UNESP]
Giongo Pedrotti, Luana
Bessel, Marina
Vieira Dos Santos Esteves, Ana Paula
Amim Junior, Joffre
Rezende Filho, Jorge
Elias, Kevin M.
Horowitz, Neil S.
Berkowitz, Ross S.
author_role author
author2 Canelas, Ana Clara
Torres, Berenice
Maesta, Izildinha [UNESP]
Giongo Pedrotti, Luana
Bessel, Marina
Vieira Dos Santos Esteves, Ana Paula
Amim Junior, Joffre
Rezende Filho, Jorge
Elias, Kevin M.
Horowitz, Neil S.
Berkowitz, Ross S.
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Maternity School of Rio de Janeiro Federal University
Faculty of Medicine of Fluminense Federal University
Young Leadership Physicians Program
Vassouras University
Universidade Estadual Paulista (UNESP)
Hospital Moinhos de Vento
Harvard Medical School
dc.contributor.author.fl_str_mv Braga, Antonio
Canelas, Ana Clara
Torres, Berenice
Maesta, Izildinha [UNESP]
Giongo Pedrotti, Luana
Bessel, Marina
Vieira Dos Santos Esteves, Ana Paula
Amim Junior, Joffre
Rezende Filho, Jorge
Elias, Kevin M.
Horowitz, Neil S.
Berkowitz, Ross S.
description OBJECTIVE: To relate preevacuation platelet count and leukogram findings, especially neutrophil/lymphocyte ratios (NLR) and platelet/lymphocyte ratios with the occurrence of gestational trophoblastic neoplasia (GTN) after complete hydatidiform mole (CHM) among Brazilian women. METHODS: Retrospective cohort study of patients with CHM followed at Rio de Janeiro Federal University, from January/2015-December/2020. Before molar evacuation, all patients underwent a medical evaluation, complete blood count and hCG measurement, in addition to other routine preoperative tests. The primary outcome was the occurrence of postmolar GTN. RESULTS: From 827 cases of CHM treated initially at the Reference Center, 696 (84.15%) had spontaneous remission and 131 (15.85%) developed postmolar GTN. Using optimal cut-offs from receiver operating characteristic curves and multivariable logistic regression adjusted for the possible confounding variables of age and preevacuation hCG level (already known to be associated with the development of GTN) we found that ≥2 medical complications at presentation (aOR: 1.96, CI 95%: 1.29-2.98, p<0.001) and preevacuation hCG ≥100,000 IU/L (aOR: 2.16, CI 95%: 1.32-3.52, p<0.001) were significantly associated with postmolar GTN after CHM. However, no blood count profile findings were able to predict progression from CHM to GTN. CONCLUSION: Although blood count is a widely available test, being a low-cost test and mandatory before molar evacuation, and prognostic for outcome in other neoplasms, its findings were not able to predict the occurrence of GTN after CHM. In contrast, the occurrence of medical complications at presentation and higher preevacuation hCG levels were significantly associated with postmolar GTN and may be useful to guide individualized clinical decisions in post-molar follow-up and treatment of these patients.
publishDate 2022
dc.date.none.fl_str_mv 2022-01-01
2023-07-29T13:31:02Z
2023-07-29T13:31:02Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1371/journal.pone.0277892
PloS one, v. 17, n. 12, p. e0277892-, 2022.
1932-6203
http://hdl.handle.net/11449/247975
10.1371/journal.pone.0277892
2-s2.0-85143200909
url http://dx.doi.org/10.1371/journal.pone.0277892
http://hdl.handle.net/11449/247975
identifier_str_mv PloS one, v. 17, n. 12, p. e0277892-, 2022.
1932-6203
10.1371/journal.pone.0277892
2-s2.0-85143200909
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv PloS one
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv e0277892
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1792962383273000960